RK

Reshma Kewalramani

Chief executive and president, Vertex Pharmaceuticals

Reshma Kewalramani is a chief executive and president at Vertex Pharmaceuticals. Their most recent Section 16 filing is from March 2026.

Known for
chief executive and president at Vertex Pharmaceuticals

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio